SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950124-04-003645
Filing Date
2004-08-06
Accepted
2004-08-06 15:10:59
Documents
10
Period of Report
2004-07-30
Items
Item 5: Other events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v00943e8vk.htm 8-K 18687
2 EXHIBIT 10.1 v00943exv10w1.txt EX-10.1 133414
3 EXHIBIT 10.2 v00943exv10w2.txt EX-10.2 92487
4 EXHIBIT 10.3 v00943exv10w3.txt EX-10.3 92495
5 EXHIBIT 10.4 v00943exv10w4.txt EX-10.4 92433
6 EXHIBIT 10.5 v00943exv10w5.txt EX-10.5 92456
7 EXHIBIT 10.6 v00943exv10w6.txt EX-10.6 92433
8 EXHIBIT 10.7 v00943exv10w7.txt EX-10.7 29938
9 EXHIBIT 10.8 v00943exv10w8.txt EX-10.8 29582
10 EXHIBIT 10.9 v00943exv10w9.txt EX-10.9 29608
  Complete submission text file 0000950124-04-003645.txt   705979
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 04957764
SIC: 2834 Pharmaceutical Preparations